Australian TGA Reports Increased Inspections in 2016

International Pharmaceutical Regulatory Monitor
A A
Australia’s Therapeutic Goods Administration increased first-time inspections of drug manufacturing facilities by 16 percent in the second half of 2016, compared to the same period a year earlier, according to the agency’s latest performance report.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor